Luminai, an AI-native enterprise automation platform purpose-built for healthcare operations, announced the close of a $38 million Series B funding round, bringing total capital raised to $60 million.1Introducing Luminai, the AI platform for health system operations | Luminai The round was led by Peak XV Partners (formerly Sequoia India & Southeast Asia), with participation from new investor Define Ventures and continued backing from existing investors, including General Catalyst and Y Combinator.2Luminai raises $38M to scale AI workflow automation platform | MobiHealthNews The San Francisco-based company disclosed the funding on April 9, 2026. The financing will accelerate Luminai's growth as large provider organizations seek scalable ways to modernize administrative work amid mounting cost pressure, staffing constraints, and increasing operational complexity.3Luminai - Revolutionizing Workflow Automation | B12
Background
The round arrives as investor appetite for AI-driven healthcare automation intensifies. Assort Health raised a $76M Series B in October 2025, pushing its total past $100 million. Candid Health secured $52.5M in Series C funding in February 2025 for revenue cycle management automation. According to research cited by Qubit Capital, AI-enabled healthcare startups captured 62% of all digital health venture funding in the first half of 2025, raising an average of $34.4 million per round-an 83% premium over non-AI startups.
The financial case for automation in healthcare administration is substantial. Administrative costs exceed $1 trillion annually for U.S. hospitals, representing 25-30% of total spending. Much of that burden stems from work spanning disconnected systems and dependent on manual interpretation of unstructured information.
The broader enterprise AI market reflects similar momentum. According to Mordor Intelligence, the enterprise AI market-worth $114.87 billion in 2026-is growing at a CAGR of 18.91%, on track to reach $273.08 billion by 2031.
Details
Luminai's platform diverges from task-specific automation tools by targeting end-to-end workflow orchestration. Rather than relying on brittle integrations or narrow bots, it applies healthcare-trained AI to interpret unstructured inputs, generate reliable intelligence, and coordinate processes across access, revenue cycle, compliance, and other administrative functions.
"Healthcare's administrative functions operate as a massive, manual coordination layer. Encoding that work into software has historically been difficult because workflows span systems and point solutions, depend on unstructured inputs, and require embedded business and clinical context at every step," said Kesava Kirupa Dinakaran, Founder and CEO of Luminai.
The company reports that customers achieve 5.3x ROI within 48 days on average across seven use cases. A partnership with Cleveland Clinic, which serves 15 million patients annually, validates the platform's enterprise scale. Luminai has driven over 12 million automations to date.
Quentin Clark, former CTO of Microsoft, SAP, and Dropbox, joins the board as part of this round. The company brings together applied AI talent with experience from organizations such as Palantir, Cruise, Google, Coinbase, and Brex, alongside healthcare operators and product leaders from Epic and Banner Health.
Outlook
Proceeds from the Series B will fund expanded product capabilities, growth of Luminai's engineering and deployment teams, and onboarding of additional enterprise customers. Health AI companies could capture an even larger share of digital health funding in 2026 as investors concentrate capital in high-demand startups; some of these firms may also explore mergers and acquisitions to offer more complete solutions to buyers, according to Healthcare Dive.
